Nonadherence with angiotensin-converting enzyme inhibitor therapy
Authors:
- Allan D StruthersASAllan D Struthers
- Robert MacFadyenRMRobert MacFadyen
- Callum FraserCFCallum Fraser
- Jess RobsonJRJess Robson
- James J MortonJMJames J Morton
- Christophe JunotCJChristophe Junot
- Eric EzanEEEric Ezan
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- High Plasma Level ofN-Acetyl-Seryl-Aspartyl-Lysyl-ProlineHypertension, 1997
- The Practical Assessment of Compliance with ACE-Inhibitor Therapy-A Novel ApproachJournal of Cardiovascular Pharmacology, 1997
- Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medicationsThe Lancet, 1996
- A Multidisciplinary Intervention to Prevent the Readmission of Elderly Patients with Congestive Heart FailureNew England Journal of Medicine, 1995
- Clinical consequences of angiotensin-converting enzyme inhibitor withdrawl in chronic heart failure: A double-blind, placebo-controlled study of quinaprilJACC, 1993
- Measurement of Converting Enzyme Activity by Antibody-Trapping of Generated Angiotensin II: Comparison With Two Other MethodsAmerican Journal of Hypertension, 1992
- Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart FailureNew England Journal of Medicine, 1991
- Negative regulator of pluripotent hematopoietic stem cell proliferation in human white blood cells and plasma as analysed by enzyme immunoassayBiochemical and Biophysical Research Communications, 1990
- Precipitating Factors Leading to Decompensation of Heart FailureArchives of internal medicine (1960), 1988
- Measurement of plasma angiotensin IIClinical Science, 1985